SILVIA
CALABUIG FARIÑAS
PROF. PERMANENTE LABORAL PPL
Hospital Universitari de Bellvitge
l'Hospitalet de Llobregat, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitari de Bellvitge (3)
2024
-
KRAS-mutant non-small cell lung cancer (NSCLC) therapy based on tepotinib and omeprazole combination
Cell Communication and Signaling, Vol. 22, Núm. 1
2021
-
Comprehensive cross-platform comparison of methods for non-invasive EGFR mutation testing: results of the RING observational trial
Molecular Oncology, Vol. 15, Núm. 1, pp. 43-56
2015
-
Role of Surgery in Patients with Recurrent, Metastatic, or Unresectable Locally Advanced Gastrointestinal Stromal Tumors Sensitive to Imatinib: A Retrospective Analysis of the Spanish Group for Research on Sarcoma (GEIS)
Annals of Surgical Oncology, Vol. 22, Núm. 9, pp. 2948-2957